期刊文献+

Stathmin基因在人成骨肉瘤细胞中的表达及意义 被引量:6

Significance of Stathmin Gene Overexpression in Osteosarcoma Cells
下载PDF
导出
摘要 背景与目的:Stathmin作为细胞信号转导分子在细胞分化及恶性肿瘤发生、发展上发挥重要作用。本研究旨在探讨Stathmin基因在人成骨肉瘤细胞中的表达,并探讨阻断其表达对该肿瘤细胞的生物学行为的影响。方法:RT-PCR及原位杂交法检测2个人成骨肉瘤细胞系及45例人成骨肉瘤组织中Stathmin基因表达情况;以高表达Stathmin基因的人成骨肉瘤细胞系SOSP-9607为靶细胞、反义Stathmin(ASODN)为阻断剂,通过MTT实验观察ASODN对该细胞系的生长抑制作用,并用流式细胞仪分析其对细胞增殖周期的影响。结果:Stathmin基因在2个成骨肉瘤细胞系高表达,45例成骨肉瘤组织中24例呈阳性表达(阳性率为53.3%),10例正常组织中2例呈弱阳性表达,Stathmin在人成骨肉瘤组织的表达与正常组织中的表达有显著性差异(P<0.05)。ASODN明显抑制成骨肉瘤细胞的生长(P<0.05)。SOSP-9607在ASODN作用下,细胞分裂阻滞在分裂期的中期,并诱导细胞发生凋亡。结论:Stathmin基因在人成骨肉瘤中高表达,该基因有望成为成骨肉瘤生物治疗中的重要靶点。 BACKGROUND &OBJECTIVE: Stathmin, a signal transduction regulatory factor, plays a crucial role in cell division and malignant tumor development. This study was designed to analyze stathmin gene expression in the tissue of osteosarcoma, and to explore the growth inhibition by blocking stathmin expression with Stathmin antisense oligodeoxynucleotide (ASODN) on cultured human osteosarcoma cell line with stathmin gene overexpression. METHODS: Reverse transcriptase polymerase chain reaction (RT PCR) and in situ hybridization methods were used to determine the expression of stathmin in two human osteosarcoma cell lines and 45 osteosarcoma tissue specimens. Using stathmin gene overexpression in human osteosarcoma cell line SOSP 9607 as target cell and stathmin ASODN as gene expression blocking agent, cell growth inhibition of stathmin ASODN was determined by MTT method, and cell growth and mitotic character was analyzed by flow cytometry. RESULTS: Both osteosarcoma cell lines of SOSP 9607 and SOSP 9901 showed stathmin gene overexpression by RT PCR method and 24 of 45 osteosarcoma specimens were stathmin positive by in situ hybridization, while there were only 2 in 10 normal tissues with mild positive signal. There was significant difference in stathmin gene expression between human osteosarcoma tissues and normal tissues (P< 0.05). The growth of osteosarcoma cells were suppressed by ASODN (P< 0.05,P< 0.01). The cell cycle of SOSP 9607 was blocked in metaphase and cell apoptosis was found. CONCLUSION: Stathmin gene displays high level expression in osteosarcoma, which may become a new target for the bio treatment for osteosarcoma.
出处 《癌症》 SCIE CAS CSCD 北大核心 2004年第5期493-496,共4页 Chinese Journal of Cancer
基金 国家自然科学基金资助项目(No.30371445)~~
关键词 STATHMIN基因 成骨肉瘤细胞 细胞表达 生物学行为 Stathmin gene Antisense oligodeoxynucleotide Osteosarcoma
  • 相关文献

参考文献10

  • 1Zhang JS,Nelson M,Wang L,et al.Identification and chromosomal localizition of CTNNAL1,a novel protein homologous to alpha-catenin[J].Genomics,1998,54(1):149-154.
  • 2杨彤涛,范清宇,张殿忠,裘秀春,刘树林,马保安,周勇.人成骨肉瘤细胞系SOSP-9607的建立及其生物学特性的观察[J].中华实验外科杂志,2000,17(2):120-121. 被引量:6
  • 3冯志华,周永兴,姚志强,张盈华,李光玉,张文彬.ASODN对白细胞抗原Ⅰ类基因表达的影响[J].中华实验和临床病毒学杂志,1998,12(4):313-315. 被引量:2
  • 4Belmont LD,Mitchison TJ.Identification of a protein that interacts with tubulin dimers and increases the catastrophe rate of microtubules [J].Cell,1996,84(4):623-631.
  • 5Segerman B,Larsson N,Holmfeldt,et al.Mutational analysis of Op1 8/stathmin-tubulin-interacting surfaces.Binding cooperativity controls tubulin GTP hydrolysis in the ternary complex [J].J Biol Chem,2000,275(46):35759-35766.
  • 6Wallon G,Rappsilber J,Mann M,et al.Model for stathmin/Op18 binding to tubulin [J].EMBO,2000,19(2):213-222.
  • 7Ahn J,Murphy M,Kratowicz S,et al.Down-regulation of the stathmin/Op18 and FKBP25 genes following p53 induction [J].Oncogene,1999,18(43):5954-5958.
  • 8Daub H,Gevaert K,Vandekerckhove J,et al.Rac/Cdc42 and p65PAK regulate the microtubule-destabilizing protein stathmin through phosphorylation at serine 16[J].J Biol Chem,2001,276(3):1677-1680.
  • 9Holmfeldt P,Brattsand G,Gullberg M.MAP4 counteracts microtubule catastrophe promotion but not tubulin-sequestering activity in intact cells[J].Curr Biol,2002,12(12):1034-1039.
  • 10Walczak CE.Microtubule dynamics and tubulin interacting proteins [J].Curr Opin Cell Biol,2000,12(1):52-56.

二级参考文献5

共引文献6

同被引文献51

  • 1王鸿丽,刘炳玉,谷苗,刘锋,吴胜明,张学敏,魏开华.改进的质谱兼容的胶内酶切方法[J].军事医学科学院院刊,2005,29(2):168-172. 被引量:14
  • 2张才云,肖自安.癌蛋白-18与头颈肿瘤[J].临床耳鼻咽喉科杂志,2006,20(3):142-144. 被引量:1
  • 3Ling Yang.Incidence and mortality of gastric cancer in China[J].World Journal of Gastroenterology,2006,12(1):17-20. 被引量:345
  • 4贺骏,阮秋蓉,杨秀萍,聂秀.Pin1和Cyclin D1在人类5种常见肿瘤中的表达及其意义[J].中国组织化学与细胞化学杂志,2006,15(6):608-612. 被引量:10
  • 5Pisani P, Parkin DM, Bray F, et al. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer, 1999,83 :18-29.
  • 6Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet, 1997,349:1498-1504.
  • 7Simons L, Tonkon M, Masana L, et al. Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome. Curr Med Res Opin, 2004, 20: 1437-1445.
  • 8Rubin CI, Atweh GF. The role of stathmin in the regulation of the cell cycle. J Cell Biochem, 2004,93 :242-250.
  • 9Walter-Yohrling J, Cao X, Callahan M, et al. Identification of genes expressed in malignant cells that promote invasion, Cancer Res, 2003,63:8939-8947.
  • 10Mistry SJ, Bank A, Atweh GF. Targeting stathmin in prostate cancer. Mol Cancer Ther, 2005,4 : 1821-1829.

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部